Inhaled nebulized nitrite is a hypoxia-sensitive NO-dependent selective pulmonary vasodilator
The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
The blood anion nitrite contributes to hypoxic vasodilation through a heme-based, nitric oxide (NO)-generating reaction with deoxyhemoglobin and potentially other heme proteins. We hypothesized that this biochemical reaction could be harnessed for the treatment of neonatal pulmonary hypertension, an NO-deficient state characterized by pulmonary vasoconstriction, right-to-left shunt pathophysiology and systemic hypoxemia. To test this, we delivered inhaled sodium nitrite by aerosol to newborn lambs with hypoxic and normoxic pulmonary hypertension. Inhaled nitrite elicited a rapid and sustained reduction ( approximately 65%) in hypoxia-induced pulmonary hypertension, with a magnitude approaching that of the effects of 20 p.p.m. NO gas inhalation. This reduction was associated with the immediate appearance of NO in expiratory gas. Pulmonary vasodilation elicited by aerosolized nitrite was deoxyhemoglobin- and pH-dependent and was associated with increased blood levels of iron-nitrosyl-hemoglobin. Notably, from a therapeutic standpoint, short-term delivery of nitrite dissolved in saline through nebulization produced selective, sustained pulmonary vasodilation with no clinically significant increase in blood methemoglobin levels. These data support the concept that nitrite is a vasodilator acting through conversion to NO, a process coupled to hemoglobin deoxygenation and protonation, and evince a new, simple and inexpensive potential therapy for neonatal pulmonary hypertension.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, recent studies have shown that much lower doses, nearphysiologic concentrations of circulating nitrite, also have vasodilatory effects in several species, 68,[107][108][109] including humans.110 -113”
From Nitrate-Nitrite-Nitric Oxide Pathway: Implications for Anesthesiology and Intensive Care (2010) · cites this paper as [112]
In the citing paper
“However, the vasodilatory potency of nitrite increases during hypoxia and acidosis probably because of enhanced reduction to bioactive nitric oxide.111,112,114”
From Nitrate-Nitrite-Nitric Oxide Pathway: Implications for Anesthesiology and Intensive Care (2010) · cites this paper as [112]
In the citing paper
“Similarly, nitrite administered via inhalation or infusion is a selective pulmonary vasodilator with increased activity in hypoxia[142–144]”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [143]
In the citing paper
“Delivered via intravenous, inhaled, or oral routes, nitrite reduces pulmonary and right heart pressures and prevents or reverses characteristic vascular remodeling and right ventricular hypertrophy (RVH) in several animal models of PAH[15,117,143,146–149].”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [143]
In the citing paper
“Heme dependent nitrite reduction to NO can be accomplished through different globin proteins including deoxyhemoglobin, deoxymyoglobin, neuroglobin, and cytoglobin [19, 87].”
From Inorganic nitrite therapy: historical perspective and future directions (2011) · cites this paper as [87]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation
Cosby, K., Partovi, K. S., Crawford, J. H., Patel, R. P., Reiter, C. D., Martyr, S., Yang, B. K., Waclawiw, M. A., Zalos, G., Xu, X., et al. (2003) · Nature Medicine · doi:10.1038/nm954 · Cited by 1,807
Self-citationIgnarro, L. J., Lippton, H., Edwards, J. C., Baricos, W. H., Hyman, A. L., Kadowitz, P. J., & Gruetter, C. A. (1981) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32738-2 · Cited by 1,633
Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction
Frostell, C., Fratacci, M. D., Wain, J. C., Jones, R., & Zapol, W. M. (1991) · Circulation · doi:10.1161/01.cir.83.6.2038 · Cited by 1,128
Inhaled Nitric Oxide in Full-Term and Nearly Full-Term Infants with Hypoxic Respiratory Failure
(1997) · New England Journal of Medicine · doi:10.1056/nejm199702273360901 · Cited by 865
Inhaled Nitric Oxide and Persistent Pulmonary Hypertension of the Newborn
Roberts, J. D., Fineman, J. R., Morin, F. C., Shaul, P. W., Rimar, S., Schreiber, M. D., Polin, R. A., Zwass, M. S., Zayek, M. M., Gross, I., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702273360902 · Cited by 804
Enzyme-independent formation of nitric oxide in biological tissues
Zweier, J. L., Wang, P., Samouilov, A., & Kuppusamy, P. (1995) · Nature Medicine · doi:10.1038/nm0895-804 · Cited by 788
Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the Newborn
Clark, R. H., Kueser, T. J., Walker, M. W., Southgate, W. M., Huckaby, J. L., Perez, J. A., Roy, B. J., Keszler, M., & Kinsella, J. P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002173420704 · Cited by 731
Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn
KINSELLA, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)92687-b · Cited by 730
Furchgott, R. F., & Bhadrakom, S. (1953) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)05163-8 · Cited by 655
Lauer, T., Preik, M., Rassaf, T., Strauer, B. E., Deussen, A., Feelisch, M., & Kelm, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221381098 · Cited by 585
Inhaled Nitric Oxide: A Selective Pulmonary Vasodilator: Current Uses and Therapeutic Potential
Ichinose, F., Roberts, J. D., & Zapol, W. M. (2004) · Circulation · doi:10.1161/01.cir.0000134595.80170.62 · Cited by 540
Gladwin, M. T., Shelhamer, J. H., Schechter, A. N., Pease-Fye, M. E., Waclawiw, M. A., Panza, J. A., Ognibene, F. P., & Cannon, R. O. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.21.11482 · Cited by 441
Self-citationInhaled Nitric Oxide in Premature Infants with the Respiratory Distress Syndrome
Schreiber, M. D., Gin-Mestan, K., Marks, J. D., Huo, D., Lee, G., & Srisuparp, P. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa031154 · Cited by 416 · cited 1×
“Therapeutically administered inhaled nitric oxide (NO) decreases pulmonary vascular resistance in newborns and adults and improves ventilation-to-perfusion matching and oxygenation; in newborns, inhaled NO reduces chronic lung damage and reduces the need for extracorporeal membrane oxygenatio”
BackgroundNagababu, E., Ramasamy, S., Abernethy, D. R., & Rifkind, J. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307572200 · Cited by 349
Kinetics and mechanism of the oxidation of human deoxyhemoglobin by nitrites.
Doyle, M. P., Pickering, R. A., DeWeert, T. M., Hoekstra, J. W., & Pater, D. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43285-1 · Cited by 334
Activation of guanylate cyclase from rat liver and other tissues by sodium azide.
Kimura, H., Mittal, C., & Murad, F. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40809-0 · Cited by 225
Factors influencing the size distribution of aerosols from jet nebulisers.
Clay, M. M., Pavia, D., Newman, S. P., & Clarke, S. W. (1983) · Thorax · doi:10.1136/thx.38.10.755 · Cited by 203
Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb.
Roberts, J. D., Chen, T. Y., Kawai, N., Wain, J., Dupuy, P., Shimouchi, A., Bloch, K., Polaner, D., & Zapol, W. M. (1993) · Circulation Research · doi:10.1161/01.res.72.2.246 · Cited by 201
Yang, B. K., Vivas, E. X., Reiter, C. D., & Gladwin, M. T. (2003) · Free Radical Research · doi:10.1080/1071576021000033112 · Cited by 200
Self-citationGladwin, M. T., Wang, X., Reiter, C. D., Yang, B. K., Vivas, E. X., Bonaventura, C., & Schechter, A. N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203236200 · Cited by 160
Self-citationXu, X., Cho, M., Spencer, N. Y., Patel, N., Huang, Z., Shields, H., King, S. B., Gladwin, M. T., Hogg, N., & Kim-Shapiro, D. B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2033883100 · Cited by 78
Self-citationHaldane, hot dogs, halitosis, and hypoxic vasodilation: the emerging biology of the nitrite anion
Gladwin, M. T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420664 · Cited by 67 · cited 1×
“The relationship between nitrite and nitric oxide has been appreciated for close to a century, with Haldane and later Hoagland recognizing that iron-nitrosylated myoglobin (NO bound to heme) formed as an end product during nitrite-based meat curin”
BackgroundSelf-citationCoates, A. L., Allen, P. D., MacNeish, C. F., Ho, S. L., & Lands, L. C. (2001) · CHEST Journal · doi:10.1378/chest.119.4.1123 · Cited by 52
Hunter, C. J., Blood, A. B., Bishai, J. M., Hickerson, A. D., Wall, D. D., Peverini, R. L., Power, G. G., & Hopper, A. O. (2004) · Pediatric Critical Care Medicine · doi:10.1097/01.pcc.0000130992.73123.bc · Cited by 43
Self-citationKinsella, J. P., Griebel, J., Schmidt, J. M., & Abman, S. H. (2002) · PEDIATRICS · doi:10.1542/peds.109.1.158 · Cited by 38
Gaston, B. M., & Hare, J. M. (2003) · New England Journal of Medicine · doi:10.1056/nejm200307243490419 · Cited by 38
Inhaled nitric oxide: Current and future uses in neonates
Kinsella, J. P., & Abman, S. H. (2000) · Seminars in Perinatology · doi:10.1053/sper.2000.20085 · Cited by 35 · cited 1×
“We hypothesized that this biochemical reaction could be harnessed for the treatment of neonatal pulmonary hypertension, an NO-deficient state characterized by pulmonary vasoconstriction, right-to-left shunt pathophysiology and systemic hypoxemi”
BackgroundCost of nitric oxide is exorbitant
Pierce, C. M., Peters, M. J., Cohen, G. A., Goldman, A. P., & Petros, A. (2002) · BMJ · doi:10.1136/bmj.325.7359.336 · Cited by 33
Nitric Oxide for Preemies — Not So Fast
Martin, R. J. (2003) · New England Journal of Medicine · doi:10.1056/nejme038165 · Cited by 18
Cost of inhaled nitric oxide therapy in neonates
Subhedar, N. V., Jauhari, P., & Natarajan, R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08632-4 · Cited by 14
Pawloski, J. R. (2003) · PubMed · Cited by 14
Cited by
The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics
Lundberg, J. O., Weitzberg, E., & Gladwin, M. T. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2466 · Cited by 2,739
Self-citationAbman, S. H., Hansmann, G., Archer, S. L., Ivy, D. D., Adatia, I., Chung, W. K., Hanna, B. D., Rosenzweig, E. B., Raj, J. U., Cornfield, D., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000329 · Cited by 1,164
Methods to detect nitric oxide and its metabolites in biological samples
Bryan, N. S., & Grisham, M. B. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.04.026 · Cited by 1,005
“The nitrite reductase activity in mammalian tissues has been linked to the mitochondrial electron transport system [17–21], protonation [16,22], deoxyhemoglobin [22,23], and xanthine oxidase [24–26].”
The emerging biology of the nitrite anion
Gladwin, M. T., Schechter, A. N., Kim-Shapiro, D. B., Patel, R. P., Hogg, N., Shiva, S., Cannon, R. O., Kelm, M., Wink, D. A., Espey, M. G., et al. (2005) · Nature Chemical Biology · doi:10.1038/nchembio1105-308 · Cited by 609
Self-citationStrategies to increase nitric oxide signalling in cardiovascular disease
Lundberg, J. O., Gladwin, M. T., & Weitzberg, E. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4623 · Cited by 576
Self-citation
Metadata
- Authors
- Hunter, C. J., Dejam, A., Blood, A. B., Shields, H., Kim-Shapiro, D. B., Machado, R. F., Tarekegn, S., Mulla, N., Hopper, A. O., Schechter, A. N., Power, G. G., & Gladwin, M. T.
- Affiliations
- National Institutes of Health (US)
- Loma Linda University Medical Center (US)
- Wake Forest University (US)
- Corresponding author
- Power, Gordon G
- Gladwin, Mark T
- ORCID
- Venue
- Nature Medicine
- Published
- 2004-09-12
- Volume
- 10
- Issue
- 10
- Pages
- 1122-1127
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2116376555
- Cited by
- 281
- References
- 32
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 1 · 2022: 4 · 2021: 8 · 2020: 5 · 2019: 10 · 2018: 15 · 2017: 17 · 2016: 14 · 2015: 12 · 2014: 15 · 2013: 12 · 2012: 23
- FWCI
- 16.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL58091, R01HL058091, HL654941)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Neonatal Respiratory Health Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Keywords
- sodium nitrite, nitric oxide, neonatal pulmonary hypertension, deoxyhemoglobin, methemoglobin, right-to-left shunt, hypoxemia, newborn lambs
- MeSH terms
- Administration, Inhalation, Aerosols, Animals, Animals, Newborn, Hypoxia, Blood Pressure, Cardiac Output, Disease Models, Animal, Hemoglobins, Humans, Hydrogen-Ion Concentration, Infant, Newborn, Methemoglobin, Nitric Oxide, Oxygen, Persistent Fetal Circulation Syndrome, Sheep, Sodium Nitrite, Vasodilator Agents, 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.